Work

Survival analysis of pyrotinib in HER2-positive metastatic breast cancer: A multicenter real-world study.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e13007

Authors: Shiyi Li, Ting Xu, Chengjun Zhu, HX Shan, Hong Xu, Jun Zhou, Lei Yang, Tongbo Yi, Xiaohong Wu, Yusong Zhang, Li Xie, Yuan Yuan, Lili Zhang

Institutions: Jiangsu Cancer Hospital, Nanjing Medical University, Jiangsu Province Hospital, First Affiliated Hospital of Soochow University, The First People’s Hospital of Lianyungang, Nantong Tumor Hospital, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Wuxi Fourth People's Hospital, Second Affiliated Hospital of Soochow University, Nanjing Drum Tower Hospital

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410822287

FWCI:

Cites:

Cited by:

Related to: 10